Long COVID-19 Infections and Infestations
Conditions
Interventions
Once consented, the participant will be able to access the baseline questionnaires on the LISTEN website. These will ask question about their Long COVID symptoms and how they are coping with them. We
Sponsors
Kingston University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age =18 years, AND 2. English or Welsh speaker or have access to someone who can act as a translator 3. Consulted with their GP to rule out serious complications or the need for further investigation in relation to persistent symptoms following COVID-19 infection, AND 4. Experience persistent illness (at least one long COVID symptom for 12 weeks or longer, AND 4.1 Positive SARS-CoV-2 PCR or antigen test (positive COVID19 test) during the acute phase of illness, OR 4.2 Positive SARS-CoV-2 antibody test (positive COVID-19 antibody test) at any time point in the absence of SARS-CoV-2 ( COVID-19) vaccination history, OR 4.3 Loss of sense of smell or taste during the acute phase in the absence of any other identified cause, OR 4.4 Symptoms consistent with SARS-CoV-2 ( COVID-19) infection during the acute phase and high prevalence of COVID-19 at time and location of onset, OR 4.5 At least one symptom consistent with SARS-CoV-2 ( COVID-19) infection during the acute phase AND close contact of a confirmed case of COVID-19 around the time of onset
Exclusion criteria
Exclusion criteria: 1. Any co-morbidities which are progressive or requiring palliative treatment. 2. Have been hospitalised for treatment of COVID-19 symptoms, during the acute phase of COVID illness. 3. Are currently participating in any COVID intervention trial (including contributing to the LISTEN co-design activities).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The impact of the LISTEN intervention on routine activities is assessed using the routine activities scale domain of the Oxford Participation and Activities Questionnaire (Ox-PAQ) at baseline and 3 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To evaluate the impact of the LISTEN intervention on emotional well-being as assessed by the relevant domain sub-scale of the Ox-PAQ, at baseline and 3 months. 2. To evaluate the impact of the LISTEN intervention on social engagement as assessed by the relevant domain sub-scale of the Ox-PAQ, at baseline and 3 months. 3. To evaluate the impact of the LISTEN intervention on health-related quality of life as assessed by the Short Form (12) Health Survey, at baseline and 3 months. 4. To evaluate the impact of the LISTEN intervention on fatigue as measured by the Fatigue Impact Scale (FIS) at baseline and 3 months. 5. To assess health-related quality of life expressed as utility using the EQ-5D-5L questionnaire, at baseline, 6 weeks and 3 months. 6. To gather information on healthcare resource use using an adapted client service receipt inventory at baseline, 6 weeks and 3 months. 7. To assess the cost-effectiveness of the LISTEN intervention using an adapted client service receipt inventory at baseline, 6 weeks and 3 months. 8. To explore key anticipated mediators of intervention outcome (namely self-efficacy in the context of COVID-19) using the generalised self-efficacy scale (GSES) with additional context-specific questions at baseline and 3 months 9. To conduct a theory-driven detailed process evaluation within the trial using validated implementation scales to assess intervention acceptability, appropriateness and feasibility (through use of the AIM, IAM and FIM questionnaires, respectively) for a selection of intervention users at 3 months and providers at 3 months and 6 months into recruitment. | — |
Countries
United Kingdom, Wales
Contacts
Public ContactClaire Potter
Outcome results
None listed